The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
The agencies are charged with making decisions that touch the lives of every American and are the source of crucial ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
For consumers, the ban on Red No. 3 represents a small victory for public health and safety. It shows that the FDA is ...
Over the years, an increasing number of studies have linked formaldehyde to cancers that are especially prevalent among Black ...
An FDA advisory committee may have ruled in elamipretide’s favor back in October, but it looks like Stealth BioTherapeutics ...
Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out of foods and drugs.
How the FDA is planning to bolster regulation, resilience and supply chain diversification across the infant formula market.
The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have progressed on prior therapy.
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...
The U.S. Food and Drug Administration has issued a recall on a popular skin moisturizer that's available nationwide. Do you have this product?
Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction, linked to ...